SPCC737.06c Antibody

What is the optimal validation method for confirming SPCC737.06c antibody specificity in S. pombe?

When validating SPCC737.06c antibody specificity, researchers should employ multiple complementary approaches. The gold standard involves comparing immunostaining patterns between wild-type cells and a knockout or knockdown strain. For essential genes like those involved in cell wall formation, a conditional knockdown system (such as the nmt81 promoter system described for sup11+) is recommended . Western blot analysis should show absence or reduction of the target band in the knockdown condition.

Additionally, epitope-tagged versions of the protein (HA, GFP) can be used as positive controls. The study of Sup11p employed both C- and N-terminal tagging with various fluorochromes, which revealed important information about protein localization and function . This combined approach helps ensure the antibody specifically recognizes your target protein and not related family members.

What sample preparation protocols are most effective for SPCC737.06c antibody immunostaining in fission yeast?

For immunostaining of S. pombe cells using SPCC737.06c antibodies, a spheroplasting protocol is strongly recommended due to the rigid cell wall structure. Based on protocols used for similar proteins:

• Fix cells with 4% formaldehyde for 30 minutes at room temperature

• Digest cell walls with Zymolyase-100T (1mg/ml) in buffer containing 1.2M sorbitol

• Permeabilize with 1% Triton X-100 for 5 minutes

• Block with 1% BSA in PBS for 1 hour

For subcellular localization studies, techniques such as those used for Sup11p can be applied, including immunogold labeling for electron microscopy and cellular fractionation via sucrose density gradient centrifugation . These methods were shown to be effective for detecting proteins in various cellular compartments including the Golgi apparatus and plasma membrane.

How can I determine the appropriate antibody concentration for Western blot applications?

Determining the optimal antibody concentration requires systematic titration to balance specific signal with minimal background. Start with a range of dilutions (typically 1:500 to 1:5000) of primary antibody. For SPCC737.06c antibody:

Always include positive controls (wild-type cells) and negative controls (no primary antibody) . When working with membrane proteins like those involved in cell wall biosynthesis, inclusion of appropriate detergents in sample preparation buffers is critical for efficient protein extraction.

What fixation methods are compatible with SPCC737.06c antibody for immunofluorescence?

Fixation methodology significantly impacts epitope preservation and antibody accessibility. For S. pombe cell wall proteins:

• Methanol fixation (-20°C, 6 minutes): Suitable for preserving protein antigens while removing lipids

• Paraformaldehyde fixation (4%, 30 minutes, RT): Preserves cellular structure but may reduce epitope accessibility

• Hybrid fixation (3.7% formaldehyde for 10 minutes followed by methanol for 1 minute): Often provides optimal results for membrane proteins

For long-term storage of fixed samples, utilize buffer systems similar to those used for other research antibodies: "Samples can be stored in IC Fixation Buffer (100 μL cell sample + 100 μL IC Fixation Buffer) for up to 3 days in the dark at 4°C with minimal impact on brightness" . Testing multiple fixation protocols is recommended as membrane protein epitopes can be particularly sensitive to fixation conditions.

How can I utilize SPCC737.06c antibody to investigate protein interactions within the cell wall synthesis pathway?

Investigating protein interactions within the cell wall synthesis pathway requires sophisticated approaches that leverage antibody specificity. Consider these methodological strategies:

• Co-immunoprecipitation (Co-IP) with SPCC737.06c antibody to identify interaction partners, followed by mass spectrometry analysis. This approach was successfully used to identify protein complexes in S. pombe cell wall biosynthesis .

• Proximity-dependent biotin labeling (BioID) paired with SPCC737.06c antibody detection to map the protein interaction network. This method allows identification of both stable and transient interactions.

• Sequential immunoprecipitation with antibodies against SPCC737.06c and known cell wall synthesis proteins such as those in the β-1,6-glucan synthesis pathway. The research on Sup11p demonstrated genetic interactions with β-1,6-glucanase family members, suggesting similar interactions might occur with SPCC737.06c .

• FRET-based assays to detect in vivo interactions, using fluorescently-labeled secondary antibodies against your primary SPCC737.06c antibody and antibodies against potential interaction partners.

The selection of detergents is critical when extracting membrane-associated proteins. Use mild non-ionic detergents (0.5-1% NP-40 or 0.1-0.5% digitonin) to preserve protein-protein interactions during extraction.

What approaches can resolve contradictory localization data for SPCC737.06c in different experimental conditions?

Resolving contradictory localization data requires a multi-faceted approach that accounts for technical variables and biological complexity:

• Compare multiple tagging strategies: As observed with Sup11p, both C- and N-terminal tagging with different fluorochromes provided complementary data. The study noted that "C- and N-terminal tagging of Sup11p with diverse fluorochromes" yielded different results, highlighting the importance of tag position .

• Employ orthogonal techniques: Combine immunofluorescence with subcellular fractionation and immunoelectron microscopy. In the case of Sup11p, "cellular fractionation via sucrose density gradient centrifugation" provided crucial information that confirmed its Golgi/post-Golgi localization .

• Analyze dynamic localization: Use time-lapse imaging with the antibody to track protein movement during the cell cycle. Proteins involved in septum formation, like those in the β-1,6-glucan synthesis pathway, often relocalize during different cell cycle stages.

• Examine contextual dependencies: Test localization under various stress conditions (osmotic shock, cell wall stress) and genetic backgrounds. Research has shown that "Kre6 signals accumulate at the sites of polarized growth" and that "the ER may be the major reservoir of Kre6" from which it "may be transported to the sites of polarized growth whenever needed" .

• Validate with super-resolution microscopy: Techniques such as STORM or PALM can resolve closely associated but distinct compartments that conventional microscopy cannot distinguish.

Create a comprehensive localization map by systematically documenting conditions that affect localization patterns:

How does post-translational modification status affect SPCC737.06c antibody recognition?

Post-translational modifications (PTMs) can significantly impact epitope accessibility and antibody recognition. For S. pombe cell wall-related proteins, key considerations include:

• Glycosylation effects: The research on Sup11p demonstrated that it "is a O-mannoprotein" and undergoes both O-mannosylation and potential N-glycosylation . These modifications can mask epitopes. Consider using:

  • Enzymatic deglycosylation (EndoH, PNGase F) prior to antibody application

  • Parallel analysis with antibodies recognizing different epitopes

  • Generation of glycosylation-specific antibodies for comprehensive analysis

• Phosphorylation status: Membrane proteins involved in cell wall synthesis are often regulated by phosphorylation. Treatment with phosphatases before immunodetection can reveal whether phosphorylation affects antibody binding.

• GPI-anchor processing: Many cell wall proteins are GPI-anchored, which affects their extraction and detection. The search results note that "various mannoproteins are covalently attached to the cell wall β-1,6-glucan via remnants of their glycosylphosphatidylinositol (GPI) -anchor" . Use PI-PLC treatment to release GPI-anchored proteins for more effective detection.

Research demonstrates that "hypo-mannosylated Sup11p can be N-glycosylated on an unusual N-X-A sequon" and that competition for modification sites occurs . This suggests that antibody recognition could vary depending on the specific modification pattern present in different experimental conditions.

What strategies can differentiate between SPCC737.06c and closely related protein family members?

Differentiating between closely related protein family members requires rigorous antibody validation and strategic experimental design:

• Epitope mapping: Generate antibodies against unique peptide sequences that distinguish SPCC737.06c from related proteins. The approach used for custom antibodies in fission yeast research includes "affinity purification of polyclonal antibodies raised against GST-fusion peptides" .

• Cross-reactivity assessment: Test antibody specificity against recombinant versions of all related family members. Create a cross-reactivity profile table:

• Genetic validation: Use strains with individual family members deleted or tagged to confirm antibody specificity. In S. pombe research, this approach revealed that "sup11+ is an essential gene that is required for β-1,6-glucan formation" .

• Immunodepletion: Pre-absorb the antibody with recombinant related proteins to remove cross-reactive antibodies before use in your experiment.

• Mass spectrometry validation: Confirm the identity of immunoprecipitated proteins using mass spectrometry. This technique was successfully employed in the characterization of Sup11p and revealed specific post-translational modifications .

What are the most common causes of non-specific binding with SPCC737.06c antibody and how can they be addressed?

Non-specific binding is a frequent challenge in antibody-based detection of S. pombe proteins. Common causes and solutions include:

• Insufficient blocking:

  • Problem: Incomplete blocking leads to antibody binding to non-specific sites

  • Solution: Extend blocking time to 2 hours using 5% BSA or 5% non-fat dry milk in TBST

  • Advanced approach: Add 0.1% Tween-20 to antibody dilution buffer to reduce hydrophobic interactions

• Cross-reactivity with related proteins:

  • Problem: Antibody recognizes conserved domains in protein families

  • Solution: Use antigen-purified antibodies as demonstrated in the study: "Antigen purification... Affinity purification of polyclonal antibodies raised against GST-fusion peptides"

  • Advanced approach: Pre-absorb antibody with recombinant related proteins

• Cell wall interference:

  • Problem: Incomplete spheroplasting leads to antibody trapping in cell wall components

  • Solution: Optimize digestion conditions with cell wall-degrading enzymes like Zymolyase

  • Advanced approach: Monitor spheroplasting efficiency microscopically before proceeding

• Fixation-induced epitope masking:

  • Problem: Fixation can alter protein structure and epitope accessibility

  • Solution: Compare multiple fixation methods (see section 1.4)

  • Advanced approach: Employ antigen retrieval techniques adapted for yeast cells

• Detection system background:

  • Problem: Secondary antibody binding to endogenous Fc receptors or biotin

  • Solution: Include IgG from the secondary antibody species in blocking buffer

  • Advanced approach: Use F(ab')2 fragments as secondary antibodies

A systematic troubleshooting approach is recommended, changing one variable at a time while maintaining detailed records of conditions and outcomes.

How can I optimize immunoprecipitation protocols for membrane-associated proteins like SPCC737.06c?

Immunoprecipitation (IP) of membrane-associated proteins presents unique challenges requiring specialized protocols:

• Effective membrane solubilization:

  • Standard approach: Use RIPA buffer with 1% NP-40 or Triton X-100

  • Improved method: For proteins like SPCC737.06c that may reside in the Golgi or post-Golgi compartments (similar to Sup11p ), use a gradient of digitonin concentrations (0.5-1.5%) to maintain native protein interactions

  • Advanced technique: Employ a two-step extraction with increasing detergent strengths

• Crosslinking optimization:

  • Standard approach: 1% formaldehyde, 10 minutes, room temperature

  • Improved method: DSP (dithiobis[succinimidyl propionate]), 1mM, 30 minutes, which is cleavable and preserves membrane protein complexes

  • Advanced technique: Implement proximity-dependent labeling (BioID or APEX) prior to IP

• Antibody coupling strategies:

  • Standard approach: Protein A/G beads + antibody

  • Improved method: Covalently couple antibody to beads using dimethyl pimelimidate

  • Advanced technique: Oriented antibody coupling maintaining antigen binding sites accessibility

• Elution conditions:

  • Standard approach: SDS sample buffer, 95°C

  • Improved method: Peptide competition elution to maintain protein complex integrity

  • Advanced technique: Sequential elution with increasing stringency to identify differential binding partners

• Verification of IP success:

  • Standard approach: Western blot detection

  • Improved method: Mass spectrometry identification

  • Advanced technique: Activity assays of immunoprecipitated protein to confirm functional integrity

Optimization protocol table for SPCC737.06c IP:

What controls are essential when using SPCC737.06c antibody in chromatin immunoprecipitation experiments?

Chromatin immunoprecipitation (ChIP) with SPCC737.06c antibody requires rigorous controls to ensure valid results, particularly when investigating potential DNA-binding roles of membrane proteins:

• Input control:

  • Purpose: Normalizes for differences in starting chromatin material

  • Implementation: Reserve 5-10% of sonicated chromatin prior to immunoprecipitation

  • Analysis: Use to calculate percent input for quantitative comparisons

• No-antibody control:

  • Purpose: Establishes background binding to beads/matrix

  • Implementation: Process identical sample without adding SPCC737.06c antibody

  • Analysis: Subtract signal from experimental samples or use as threshold

• Isotype control:

  • Purpose: Controls for non-specific binding of antibody constant regions

  • Implementation: Use matched concentration of irrelevant antibody of same isotype

  • Analysis: Compare enrichment patterns to identify specific versus non-specific signals

• Positive genomic locus control:

  • Purpose: Confirms ChIP protocol functionality

  • Implementation: Include primers for loci known to be bound by transcription factors

  • Analysis: Verify enrichment at these sites as technical validation

• Negative genomic locus control:

  • Purpose: Establishes baseline for non-specific DNA binding

  • Implementation: Include primers for heterochromatic regions or unexpressed genes

  • Analysis: Should show minimal enrichment compared to specific targets

• Knockout/knockdown control:

  • Purpose: Validates antibody specificity in ChIP context

  • Implementation: Perform parallel ChIP in cells with reduced SPCC737.06c expression

  • Analysis: Should show significantly reduced signal at target loci

• Sequential ChIP control:

  • Purpose: Validates co-occupancy for protein interaction studies

  • Implementation: Re-ChIP with antibody against known interacting partner

  • Analysis: Enrichment indicates co-occupancy at specific genomic regions

For membrane proteins like those involved in cell wall synthesis pathways, which may have unexpected nuclear roles, these controls are essential to distinguish genuine chromatin association from technical artifacts.

How can SPCC737.06c antibody be used to investigate the protein's role in septum formation and cell wall synthesis?

Investigation of SPCC737.06c's role in septum formation and cell wall synthesis can be systematically approached using antibody-based techniques:

• Temporal-spatial localization analysis:

  • Method: Time-lapse immunofluorescence microscopy throughout cell cycle stages

  • Expected patterns: Based on similar proteins like Sup11p, localization may shift "during septum assembly" with "accumulation of cell wall material at the centre of the closing septum"

  • Advanced approach: Super-resolution microscopy to resolve distinct septum layers

• Co-localization with septum markers:

  • Method: Dual immunolabeling with SPCC737.06c antibody and antibodies against known septum components

  • Expected patterns: Determine if SPCC737.06c associates with primary septum (β-1,3-glucan) or secondary septum components

  • Advanced approach: 3D reconstruction of septum architecture using confocal z-stacks

• Cell wall compositional analysis after perturbation:

  • Method: Immunoelectron microscopy to assess β-1,6-glucan distribution following SPCC737.06c depletion

  • Expected outcomes: If similar to Sup11p, expect "β-1,6-glucan was absent from the cell wall" in depletion conditions

  • Advanced approach: Correlative light and electron microscopy to connect protein localization with ultrastructural changes

• Protein complex isolation during septation:

  • Method: Synchronize cells and perform immunoprecipitation at defined septation stages

  • Expected outcomes: Identification of stage-specific interaction partners

  • Advanced approach: Proximity labeling (BioID) to capture transient interactions

• Genetic interaction mapping:

  • Method: Immunodetection of SPCC737.06c in various cell wall synthesis mutant backgrounds

  • Expected patterns: Altered localization, abundance, or modification state

  • Advanced approach: Synthetic genetic array analysis with immunoblotting readout

Key experimental approach based on Sup11p research:
"Depletion of Sup11p changes β-glucan partitioning in the septum and the lateral cell wall" and "Analysis of the nmt81-sup11 mutant cell wall brought evidence that Gas2p, a member of the α-1,3-glucanosyl-transferases GH72 family, plays a crucial role in accumulating the observed septum material depositions" . Similar approaches could reveal SPCC737.06c's specific contributions to septum architecture.

What techniques can determine if SPCC737.06c antibody recognizes glycosylated epitopes?

Determining whether SPCC737.06c antibody recognizes glycosylated epitopes requires specialized approaches to distinguish protein and carbohydrate recognition:

• Enzymatic deglycosylation analysis:

  • Method: Treat protein samples with specific glycosidases prior to immunodetection

  • Enzymes to test: EndoH (N-linked), O-glycosidase, α-mannosidase

  • Expected outcome: Reduced or abolished antibody binding indicates glycosylation-dependent epitope

  • Advanced approach: Time-course deglycosylation to identify specific glycan structures affecting recognition

• Parallel detection with glycan-specific lectins:

  • Method: Compare SPCC737.06c antibody binding with lectin binding patterns

  • Lectins to test: ConA (mannose), WGA (N-acetylglucosamine), PNA (galactose)

  • Expected outcome: Co-localization suggests glycan contribution to epitope

  • Advanced approach: Competition assays between antibody and lectins

• Recombinant expression in glycosylation-deficient systems:

  • Method: Express SPCC737.06c in bacterial systems (lacking glycosylation) and compare antibody recognition with native protein

  • Expected outcome: Differential recognition indicates glycosylation dependency

  • Advanced approach: Site-directed mutagenesis of potential glycosylation sites

• Glycoform-specific antibody generation:

  • Method: Develop antibodies against specific glycoforms using purified protein glycoforms

  • Expected outcome: Antibodies that discriminate between glycosylation states

  • Advanced approach: Epitope mapping of glycosylation-dependent antibodies

• Mass spectrometry correlation:

  • Method: Correlate antibody recognition with glycopeptide profiles determined by mass spectrometry

  • Expected outcome: Identification of specific glycan structures affecting antibody binding

  • Advanced approach: Targeted glycoproteomics focusing on immunoprecipitated material

Research on similar proteins reveals important considerations: "Sup11p:HA is a O-mannoprotein" and "unusual N-glycosylation of Sup11p:HA in the oma4 mutant background" where "hypo-mannosylated Sup11p can be N-glycosylated on an unusual N-X-A sequon" . This suggests that recognition of SPCC737.06c might similarly depend on its glycosylation status, which can vary with genetic background.

How can I design experiments to detect SPCC737.06c expression changes during cell wall stress responses?

Designing experiments to detect SPCC737.06c expression changes during cell wall stress requires a comprehensive approach combining quantitative protein detection with functional analysis:

• Time-course stress induction protocol:

  • Stressors to test: Calcofluor white (chitin/glucan binding), Congo red (β-glucan binding), caspofungin (β-1,3-glucan synthesis inhibitor)

  • Time points: 0, 15, 30, 60, 120, 240 minutes after stress application

  • Controls: Matched osmotic stress (sorbitol) to distinguish specific cell wall stress from general osmotic response

• Quantitative Western blot analysis:

  • Method: Standardized protein extraction and quantitative immunoblotting with SPCC737.06c antibody

  • Normalization: Use both total protein staining (REVERT) and housekeeping proteins (α-tubulin)

  • Analysis: Calculate fold-change in protein levels relative to untreated controls

  • Advanced approach: Phospho-specific detection to identify stress-induced post-translational modifications

• Subcellular localization shifts:

  • Method: Immunofluorescence microscopy before and after stress application

  • Analysis: Quantify changes in distribution pattern (e.g., polarized vs. uniform distribution)

  • Advanced approach: Live-cell imaging with fluorescently-labeled antibody fragments to track dynamic relocalization

• Correlation with transcriptional changes:

  • Method: Parallel RT-qPCR analysis of SPCC737.06c mRNA levels

  • Analysis: Compare protein and mRNA dynamics to identify translational or post-translational regulation

  • Advanced approach: Polysome profiling to assess translational efficiency

• Protein interaction dynamics:

  • Method: Co-immunoprecipitation under normal and stress conditions

  • Analysis: Identify stress-specific interaction partners

  • Advanced approach: FRET-based biosensors to detect conformation changes during stress

Sample experimental design table:

Research on similar proteins demonstrates that "a transcriptome analysis performed on the nmt81-sup11 mutant identified significant regulation of several cell wall glucan modifying enzymes" , suggesting that SPCC737.06c may similarly participate in transcriptional or post-transcriptional stress response pathways.

How can SPCC737.06c antibody be used in high-throughput screening of cell wall mutant phenotypes?

Employing SPCC737.06c antibody in high-throughput screening of cell wall mutants enables systematic characterization of phenotypic variations:

• Automated immunofluorescence microscopy platform:

  • Method: 96-well format immunostaining with SPCC737.06c antibody on S. pombe deletion library

  • Analysis: Machine learning-based image analysis to classify localization patterns

  • Expected outcomes: Identification of genes affecting SPCC737.06c localization or abundance

  • Advanced approach: Multiplexed antibody detection with additional cell wall markers

• Flow cytometry-based screening:

  • Method: Permeabilized cells stained with fluorescently-labeled SPCC737.06c antibody

  • Analysis: Quantify signal intensity changes across mutant collection

  • Expected outcomes: Identification of mutants with altered expression or accessibility

  • Advanced approach: Multiparameter analysis with cell cycle markers to detect cell cycle-dependent changes

• Reverse phase protein array (RPPA):

  • Method: Spot protein extracts from mutant collection onto nitrocellulose, probe with SPCC737.06c antibody

  • Analysis: Quantitative comparison of protein levels across hundreds of mutants

  • Expected outcomes: Identification of genetic modulators of SPCC737.06c expression

  • Advanced approach: Parallel arrays with phospho-specific antibodies to detect regulatory changes

• Yeast two-hybrid or split-ubiquitin screening:

  • Method: Use SPCC737.06c as bait against S. pombe cDNA library, verify interactions with co-immunoprecipitation

  • Analysis: Identify novel interaction partners and validate with SPCC737.06c antibody

  • Expected outcomes: Map of SPCC737.06c protein interaction network

  • Advanced approach: Conditional screening under cell wall stress conditions

• Cell wall composition analysis pipeline:

  • Method: Correlate SPCC737.06c levels (via quantitative immunoblotting) with cell wall composition

  • Analysis: Multivariate statistical analysis to identify relationships between protein expression and wall structure

  • Expected outcomes: Functional clusters of mutants with similar phenotypic signatures

  • Advanced approach: Integration with transcriptomic and proteomic datasets

Based on research with similar proteins, this approach could identify new components in pathways like those identified for Sup11p, which "is required for β-1,6-glucan formation" and "interacts genetically with β-1,6-glucanase family members" .

What emerging technologies can enhance the sensitivity and specificity of SPCC737.06c antibody-based detection?

Emerging technologies offer significant improvements to antibody-based detection of challenging targets like SPCC737.06c:

• Proximity ligation assay (PLA):

  • Principle: Oligonucleotide-conjugated secondary antibodies generate amplifiable DNA signal when in close proximity

  • Advantage: 1000-fold increased sensitivity over conventional immunofluorescence

  • Application: Detect low-abundance SPCC737.06c or visualize specific protein-protein interactions

  • Implementation: Use paired antibodies (SPCC737.06c + interaction partner)

• Single-molecule detection methods:

  • Principle: Direct visualization of individual antibody-antigen binding events

  • Advantage: Eliminates background signal, enables quantitative stoichiometry determination

  • Application: Precise quantification of SPCC737.06c molecules per cellular compartment

  • Implementation: Total internal reflection fluorescence (TIRF) microscopy with fluorescently-labeled antibodies

• Mass cytometry (CyTOF):

  • Principle: Metal-tagged antibodies detected by time-of-flight mass spectrometry

  • Advantage: No spectral overlap, allows simultaneous detection of >40 parameters

  • Application: Multiplex analysis of SPCC737.06c with numerous cell wall components

  • Implementation: Metal-conjugated antibodies against SPCC737.06c and related proteins

• Nanobody engineering:

  • Principle: Single-domain antibody fragments with superior tissue penetration

  • Advantage: Access restricted epitopes in dense structures like cell walls

  • Application: Improved detection of SPCC737.06c in intact cells

  • Implementation: Camelid-derived nanobodies against specific SPCC737.06c epitopes

• Expansion microscopy:

  • Principle: Physical expansion of specimens to improve spatial resolution

  • Advantage: Achieves super-resolution with standard microscopes, improves antibody accessibility

  • Application: Detailed localization of SPCC737.06c within subdomains of cell wall/septum

  • Implementation: Hydrogel embedding followed by antibody staining and expansion

• APEX proximity labeling:

  • Principle: Antibody-APEX fusion catalyzes biotin deposition on proximal proteins

  • Advantage: Maps protein neighborhood in living cells

  • Application: Identify proteins in proximity to SPCC737.06c under various conditions

  • Implementation: Secondary antibody-APEX conjugates applied to fixed cells

These technologies could significantly enhance studies similar to those conducted on Sup11p, where "subcellular localization studies" and "topology analysis" were critical for understanding protein function .

How can computational modeling incorporate SPCC737.06c antibody data to predict cell wall architecture?

Integrating SPCC737.06c antibody data into computational models offers powerful insights into cell wall architecture and dynamics:

• Quantitative spatial distribution modeling:

  • Input data: 3D immunofluorescence intensity maps of SPCC737.06c localization

  • Modeling approach: Gaussian process regression to create continuous probability density functions

  • Output: Predicted concentration gradients across cell compartments

  • Validation: Cross-reference with electron microscopy immunogold labeling

  • Application: Predict sites of active cell wall synthesis or remodeling

• Temporal-spatial correlation analysis:

  • Input data: Time-lapse antibody staining throughout cell cycle

  • Modeling approach: Hidden Markov Models to identify state transitions

  • Output: Probabilistic models of SPCC737.06c redistribution during growth and division

  • Validation: Test predictions with targeted genetic perturbations

  • Application: Identify critical time points for functional intervention

• Protein interaction network modeling:

  • Input data: Co-immunoprecipitation results under various conditions

  • Modeling approach: Bayesian networks to infer causal relationships

  • Output: Predictive models of pathway activation/inhibition

  • Validation: Test with targeted protein depletion experiments

  • Application: Identify key nodes for therapeutic targeting

• Multiscale cell wall architecture simulation:

  • Input data: SPCC737.06c localization relative to other cell wall components

  • Modeling approach: Agent-based modeling of glucan synthesis and crosslinking

  • Output: Emergent patterns of wall organization based on molecular interactions

  • Validation: Compare with cell wall ultrastructure from electron microscopy

  • Application: Predict consequences of perturbations to SPCC737.06c function

• Integrative multi-omics modeling:

  • Input data: Antibody-based proteomics, transcriptomics, and glycomics

  • Modeling approach: Tensor factorization to identify coordinated patterns

  • Output: Integrated regulatory model of cell wall biosynthesis

  • Validation: Test predictions with CRISPR-based perturbations

  • Application: Design targeted interventions to alter specific aspects of cell wall architecture

These computational approaches could extend findings from studies of related proteins where "immunogold labeling of fission yeast cells revealed that the β-1,6-glucan is located directly underneath the outer electron dense layer linking the α-galactomanan to the glucan matrix" , providing mechanistic explanations for experimental observations.